< Back to previous page
Project
Development of novel anti-inflammatory strains to counterbalance dysbiosis in inflammatory bowel disorders. (IWT541)
The main objective of the current project is the development of a product consisting of anaerobic, butyric acid-producing bacteria of Clostridium cluster IV and XIVa, with application in the treatment of IBD in humans and NE in chickens.
Date:1 Jan 2011 → 31 Dec 2014
Keywords:Applied Biology, dysbiosis
Disciplines:Biological sciences